Location
United States, North America
Cheque size
$100K - $5M
Investment Stage
Seed
Series A
Focus Areas
BioTech
Pharmaceuticals
About Investor
Katie Mangialardi is currently an MD Candidate at the Renaissance School of Medicine at Stony Brook University. Her investing work is associated with Autism Impact Fund, with a focus on biotech, pharmaceuticals, diagnostics, and therapeutics, typically at Seed and Series A, with an investment range of $100K - $5.0M. Her background includes helping build a venture effort aimed at unmet needs across autism, mental health, and other complex chronic conditions.
Similar Investors
AL
Abdul Ly
United States, North America
$1M - $4M
Seed
,Series A
,PS
Paul Straub
United States, North America
$100K - $2M
Pre Seed
,Seed
,SA
Shaun Abrahamson
United States, North America
$250K - $1M
Pre Seed
,Seed
,RF
Riley Florsheim
United States, North America
$100K - $5M
Pre Seed
,Seed
,SB
Steve Brownlie
United States, North America
$250K - $1.4M
Pre Seed
,Seed
,DG
Danielle Graham
Canada, North America
$100K - $300K
Pre Seed
,Seed
,Is this Your Profile?
If you have any updates, please fill out our form.